Bayer

AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
AACR
Bayer
Aliqopa
non-Hodgkin lymphoma
follicular lymphoma
Zydelig
Flag link:
Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push
Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push
Fierce Biotech
Metagenomi
Bayer
funding
venture capital
Flag link:
Bayer unveils first look at its post-Xarelto, post-Eylea life—and it's better than expected
Bayer unveils first look at its post-Xarelto, post-Eylea life—and it's better than expected
Fierce Pharma
Bayer
Xarelto
Eylea
patents
Stivarga
Verquvo
Flag link:
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Clarivate
Biogen
Eisai
aducanumab
UCB Pharma
bimekizumab
Relugolix
Pfizer
Takeda
Myovant
vericiguat
Bayer
Merck
Flag link:
Bayer’s gene therapy juggling act
Bayer’s gene therapy juggling act
EP Vantage
Bayer
gene therapy
AskBio
Flag link:
Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production
Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production
Xtalks
vaccines
COVID-19
drug manufacturing
Bayer
GSK
Sanofi
CureVac
Flag link:
Bayer agrees to help CureVac produce coronavirus vaccine
Bayer agrees to help CureVac produce coronavirus vaccine
BioPharma Dive
Bayer
CureVac
COVID-19
vaccines
Flag link:
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Endpoints
Bayer
Aimmune
peanut allergy
Ukko
Nestle
Flag link:
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
BioPharma Dive
Bayer
AskBio
M&A
gene therapy
Flag link:
Can Merck and Bayer's newly approved Verquvo stand out in an ever-more-competitive heart failure field?
Can Merck and Bayer's newly approved Verquvo stand out in an ever-more-competitive heart failure field?
Fierce Pharma
Merck
Bayer
FDA
Verquvo
vericiguat
chronic heart failure
Flag link:
The top 10 largest biopharma M&A deals in 2020
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Flag link:
Bayer pharma chief admits to unfillable revenue gap despite potential blockbuster launches
Bayer pharma chief admits to unfillable revenue gap despite potential blockbuster launches
Fierce Pharma
Bayer
Eylea
Xalreto
Flag link:
JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
Fierce Biotech
CureVac
Bayer
vaccines
COVID-19
JPMHC 2021
Flag link:
Biopharma Companies Entering 2021 With New Collabs, Partnerships
Biopharma Companies Entering 2021 With New Collabs, Partnerships
BioSpace
M&A
Argenx
Zai Lab
Dewpoint Therapeutics
Pfizer
CureVac
Bayer
Sanofi
Nurix Therapeutics
Flag link:
mRNA latecomer CureVac recruits Bayer to speed COVID-19 vaccine to market
mRNA latecomer CureVac recruits Bayer to speed COVID-19 vaccine to market
Fierce Pharma
MRNA
CureVac
Bayer
COVID-19
vaccines
Flag link:
Biotech Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio
Biotech Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio
Fierce Biotech
Bayer
venture capital
gene therapy
Senti Biosciences
Flag link:
Astrazeneca shows megamergers were still possible in 2020
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Flag link:
Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration
Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration
BioSpace
Bayer
CAR-T
cell therapy
Atara
Flag link:
Bayer creates cell and gene therapy platform to support partners
Bayer creates cell and gene therapy platform to support partners
Fierce Biotech
Bayer
cell therapy
gene therapy
Asklepios BioPharmaceutical
Flag link:
Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M
Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M
Fierce Biotech
Argenx
Bayer
FDA
priority reviews
efgartigimod
ITP
Flag link:

Pages